Condition: Esophageal Squamous Cell Carcinoma
Interventions: Drug: SHR-1210; Drug: Placebo
Sponsors: The First Affiliated Hospital of Zhengzhou University; Jiangsu HengRui Medicine Co., Ltd.
Not yet recruiting
http://bit.ly/2sYUCC3
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,
Ετικέτες
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Summary Insulinomas are rare neuroendocrine tumours that classically present with fasting hypoglycaemia. This case report discusses an un...
-
The online platform for Taylor & Francis Online content New for Canadian Journal of Remote Sen...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου